T/HZMZ 001-2023 Active Group standards

T/HZMZ 001-2023 Cosmetic Ingredient: Soluble Collagen

Publish Date: 2024-12-18 Implement Date: 2024-12-19 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/HZMZ 001-2023

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Cosmetics and beauty products

Publish Date: 2024-12-18

Implement Date: 2024-12-19

Scope

Scope: This document specifies the terms and definitions, technical requirements, testing methods, inspection rules, labeling, packaging, transportation, storage, and shelf life of soluble collagen used as raw materials in cosmetics. This document applies to soluble collagen of type XVII collagen protein prepared by DNA recombination technology as a cosmetic raw material. Main technical content: I. Purpose and Significance In recent years, the safety of skincare products has received increasing attention from both the government and consumers. The newly promulgated and implemented Regulations on the Supervision and Administration of Cosmetics Safety also prioritize the safety of skincare products to better ensure quality and safety and promote the development of cosmetic products. With the continuous development of basic theories, technical methods, and clinical medical research in scientific fields such as gene recombination and proteomics, recombinant collagen has increasingly become an important biomaterial, providing new ideas and methods for the research and development of related cosmetic products. Recombinant humanized collagen is a collagen protein specifically encoded by a specific type of gene, composed of full-length or partial amino acid sequences, or a combination containing human collagen functional fragments, prepared by DNA recombination technology. Related regulations and standards for recombinant humanized collagen are listed in the following table: - National Medical Products Administration, Center for Drug Evaluation and Research: Announcement on the Issuance of Guidelines for the Registration Review of Medical Device Products Containing Recombinant Collagen Dressings, etc. (No. 16, 2022) - Medical industry standard: YY/T 1888-2023: Recombinant Humanized Collagen - Medical industry standard: YY/T 1849-2022: Recombinant Collagen - T/ZGKSL 004-2023: Cosmetic Raw Materials of Recombinant Collagen - T/ZGKSL 005-2023: Quality Req